Terrillion Scott's Form 4 filing
Tvardi Therapeutics, Inc. (TVRD) · filed Mar 4, 2024
- Accession no.
- 0001415889-24-006282
- Filed
- Mar 4, 2024
- Trade date
- Feb 29, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $2.93K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Terrillion ScottCIK 0001706426 | Officer (SEC'Y; CHIEF COMPLIANCE & G.C.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | Common Stock | SSaleDisposed | −3,293 | $0.89 | −$2,930.77 | 91,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.